The Biden administration is looking at ways to broaden access to potential COVID-19 antiviral pills when supply increases in the coming months, the Wall Street Journal reported on Friday, citing a person familiar with the plans.
November 19, 2021, 4:59 PM -
Molnupiravir, an oral pill from Merck & Co Inc and Ridgeback Biotherapeutics LP that is also under regulatory review, may be included in the government's plan to make it commercially available, the journal reported, citing the person. Pfizer pointed to its supply deal with the U.S. government announced on Thursday, in response to a Reuters request for comment. Merck and the U.S. Department of Health and Human Services did not immediately respond.
The U.S. government is pushing the drugmakers to boost production, the report said, adding that commercial sales could occur when supply of the pills increases.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA OKs Pfizer, Moderna COVID-19 booster shot for all adultsInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Weiterlesen »
Covid-19 Boosters From Pfizer-BioNTech, Moderna Cleared for All U.S. AdultsThe FDA authorized the Pfizer-BioNTech and Moderna booster shots for anyone 18 and over, no matter which vaccine they received earlier
Weiterlesen »
FDA authorizes Pfizer/BioNTech, Moderna COVID-19 boostersThe U.S. Food and Drug Administration on Friday authorized booster doses of COVID-19 vaccines for all adults who were vaccinated with the Pfizer Inc and partner BioNTech SE shot and the Moderna Inc shot.
Weiterlesen »